Acadia Pharmaceuticals (ACAD) Revenue Growth (1y) (2011 - 2026)
Acadia Pharmaceuticals (ACAD) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - | - |
| 10 | Acadia Pharmaceuticals | 4.39 Bn | 3.53 Bn | 243.27 Mn | 9.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.72% |
| Dec 31, 2025 | 9.39% |
| Sep 30, 2025 | 11.27% |
| Jun 30, 2025 | 9.34% |
| Mar 31, 2025 | 18.70% |
| Dec 31, 2024 | 12.36% |
| Sep 30, 2024 | 18.28% |
| Jun 30, 2024 | 46.44% |
| Mar 31, 2024 | 73.75% |
| Dec 31, 2023 | 69.27% |
| Sep 30, 2023 | 61.96% |
| Jun 30, 2023 | 22.79% |
| Mar 31, 2023 | 2.59% |
| Dec 31, 2022 | 4.38% |
| Sep 30, 2022 | -0.68% |
| Jun 30, 2022 | 16.79% |
| Mar 31, 2022 | 8.37% |
| Dec 31, 2021 | 8.06% |
| Sep 30, 2021 | 9.15% |
| Jun 30, 2021 | 4.65% |